In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin

References

• Cardenas ME, Cruz MC, Del Poeta M, et al. Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin Microbiol Rev 1999; 12: 583–611
   PubMed Web of Science ®Google Scholar
• Pettit GR, Cichacz ZA, Gao F, et al. Isolation and structure of the remarkable human cancer cell growth inhibitors spongistatins 2 and 3 from an Eastern Indian Ocean Spongia spp. J Chem Soc Chem Commun 1993; 14: 1166–1168
   Google Scholar
• Pettit GR, Cichacz ZA, Herald CL, et al. Isolation and structure of spongistatin 1. J Org Chem 1993; 58: 1302–1304
   Web of Science ®Google Scholar
• Pettit GR, Herald CL, Cichacz ZA, et al. Antineoplastic agents 293. The exceptional human cancer cell growth inhibitors spongistatins 6 and 7. N Prod Lett 1993; 3: 239–244
   Google Scholar
• Pettit GR, Herald CL, Cichacz ZA, et al. Isolation and structure of the powerful human cancer cell growth inhibitors spongistatins 4 and 5 from an African Spirastrella spinispirulifera (Porifera). J Chem Soc Chem Commun 1993; 24: 1805–1807
   Google Scholar
• Paterson I, Chen DYK, Coster MJ, et al. Stereocontrolled total synthesis of (+)-altohytrin A/spongistatin 1. Angew Chem (Int Edn) 2001; 40: 4055–4060
   Google Scholar
• Smith AB, Doughty VA, Lin QY, et al. The spongistatins: Architecturally complex natural products. Part one: a formal synthesis of (+)-spongistatin 1 by construction of an advanced ABCD fragment. Angew Chem (Int Edn) 2001; 40: 191–195
   Google Scholar
• Pettit RK, McAllister SC, Pettit GR, et al. A broad spectrum antifungal from the marine sponge Hyrtios. Int J Antimicrob Agents 1998; 9: 147–152
   Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard. Document M27-A2, 2002.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard. Document M38-A, 2002.
   Google Scholar
• Sanglard D, Ischer D, Bille J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 2001; 45: 1174–1183
   PubMed Web of Science ®Google Scholar
• Manavathu EK, Vazquez JA, Chandrasekar PH. Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent. Int J Antimicrob Agents 1999; 12: 213–219
   PubMedGoogle Scholar
• Cross EW, Park S, Perlin DS. Cross-resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis. Microb Drug Resist 2000; 6: 155–161
   PubMed Web of Science ®Google Scholar
• Craig WA, Gudmundsson S. The postantibiotic effect. Antibiotics in Laboratory Medicine3rd edn, V Lorian. Williams & Wilkins, Baltimore 1991; 403–31
   Google Scholar
• Brummer E, Maqbool A, Stevens DA. In vivo GM–CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages. J Leuk Biol 2001; 70: 868–872
   PubMed Web of Science ®Google Scholar
• Hata K, Kimura J, Miki H, et al. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of Aspergillosis, Candidiasis, and Cryptococcosis. Antimicrob Agents Chemother 1996; 40: 2243–2247
   PubMed Web of Science ®Google Scholar
• Pringle JR, Adams AE, Drubin DG, et al. Immunofluoresence methods for yeasts. Methods Enzymol 1991; 194: 565–602
   PubMedGoogle Scholar
• Woyke T, Roberson RW, Pettit GR, et al. Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans. Antimicrob Agents Chemother 2002; 46: 3802–3808
   PubMed Web of Science ®Google Scholar
• MacKenzie DW, Odds FC. Non-identity and authentication of two major reference strains of Candida albicans. J Med Vet Mycol 1991; 29: 255–261
   Google Scholar
• Jessup, CJ, Wallace, TL, Ghannoum, MA. Evaluation of antifungal activity of nyotran against various pathogenic fungi. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Washington, DC: American Society for Microbiology, 1997: 37.
   Google Scholar
• Huffaker TC, Thomas JH, Botstein D. Diverse effects of betatubulin mutations on microtubule formation and function. J Cell Biol 1988; 106: 1997–2010
   PubMed Web of Science ®Google Scholar
• Jacobs CW, Adams AE, Szaniszlo PJ, et al. Functions of microtubules in the Saccharomyces cerevisiae cell cycle. J Cell Biol 1988; 107: 1409–1426
   PubMed Web of Science ®Google Scholar
• Pringle JR, Hartwell LH. Saccharomyces cerevisiae cell cycle. Molecular Biology of the Yeast Saccharomyces, JN Strathern, EW Jones, JR Broach. Cold Spring Harbor, Harbor, NY 1981; 97–142
   Google Scholar
• Del Poeta M, Chen S, Von Hoff D, et al. Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells. Antimicrob Agents Chemother 1999; 43: 2862–2868
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Motawy MS, Abu-Hatab MA, et al. Interactive effect of antifungal and antineoplastic agents on yeasts commonly prevalent in cancer patients. Antimicrob Agents Chemother 1989; 33: 726–730
   PubMed Web of Science ®Google Scholar
• Holloman DW, Butters JA, Barker H. Tubulins: a target for anti-fungal agents. Anti-infectives: Recent Advances in Chemistry and Structure Activity Relationships, PH Bentley, PJ O'Hanlon. Royal Society of Chemistry, London 1997; 152–156
   Google Scholar
• Little M, Seehaus T. Comparative analysis of tubulin sequences. Comp Biochem Physiol B 1988; 90: 655–670
   Google Scholar
• Woyke T, Pettit GR, Winkelmann G, et al. In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE. Antimicrob Agents Chemother 2001; 45: 967–1000
   Google Scholar
• Bai R, Cichacz ZA, Herald CL, et al. Spongistatin 1, a highly cytotoxic, sponge-derived marine natural product that inhibits mitosis, a microtubule assembly, and the binding of vinblastine to tubulin. Mol Pharmacol 1993; 44: 757–766
   PubMed Web of Science ®Google Scholar
• Ovechkina YY, Pettit RK, Cichacz ZA, et al. Unusual antimicrotubule activity of the antifungal agent spongistatin 1. Antimicrob Agents Chemother 1999; 43: 1993–1999
   Google Scholar
• Craig WA, Gudmundsson S. Postantibiotic effect. Antibiotics in Laboratory Medicine3rd edn, V Lorian. Williams & Wilkins, Baltimore 1996; 296–329
   Google Scholar
• Turnidge JD, Gudmundsson S, Vogelman B, et al. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J Antimicrob Chemother 1994; 34: 83–92
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Messer SA, et al. National surveillance of nosocomial bloodstream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagnos Microbiol Inf Dis 1998; 30: 121–129
   PubMed Web of Science ®Google Scholar
• Beck-Sague˘ CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247–1251
   PubMed Web of Science ®Google Scholar
• Birley HD, McDonald P, Parry C, et al. Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis. Int J STD AIDS 1995; 6: 353–355
   PubMedGoogle Scholar
• Joseph-Horne THD. Molecular mechanisms of azole resistance in fungi. FEMS Microbiol Lett 1997; 149: 141–149
   PubMed Web of Science ®Google Scholar
• Joseph-Horne THD, Loeffler RS, Kelly SL. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob Agents Chemother 1995; 39: 1526–1529
   PubMed Web of Science ®Google Scholar
• Viard JP, Pertuiset N, Rothschild C, et al. Fulminant cryptococcal infections in HIV-infected patients on oral fluconazole. Lancet 1995; 346: 118
   Google Scholar
• Agard DA, Hiraoka Y, Shaw P, et al. Fluorescence microscopy in three dimensions. Methods Cell Biol 1989; 30: 353–377
   PubMedGoogle Scholar
• Scalettar BA, Swedlow JR, Sedat JW, et al. Dispersion, aberration and deconvolution in multi-wavelength fluorescence images. J Microsc 1996; 182: 50–60
   Google Scholar
• Amberg DC. Three-dimensional imaging of the yeast actin cytoskeleton through the budding cell cycle. Mol Biol Cell 1998; 9: 3259–3262
   PubMedGoogle Scholar
• McNally JG, Karpova T, Cooper J, et al. Three-dimensional imaging by deconvolution microscopy. Methods 1999; 19: 373–385
   PubMed Web of Science ®Google Scholar
• King SM, Hyams JS. The mitotic spindle of Sacchromyces cerevisiae: assembly, structure and function. Micron 1982; 13: 93–117
   Google Scholar
• Heath IB, Ashton ML, Kaminskyj SGW. Mitosis as a phylogenetic marker among the yeasts- review and observations on novel mitotic systems in freeze-substituted cells of the Taphrinales. Stud Mycol 1987; 30: 1696–1725
   Google Scholar
• McCully EK, Robinow CF. Mitosis in heterobasidiomycetous yeasts. I. Leucosporidium scotti (Candida scotti). J Cell Sci 1972; 10: 857–881
   PubMed Web of Science ®Google Scholar
• Mochizuki T. Three-dimensional reconstruction of mitotic cells of Cryptococcus neoformans based on serial selection electron microscopy. Nippon Ishinkin Gakkai Zasshi 1998; 39: 123–127
   Google Scholar
• Mochizuki T, Tanaka S, Watanabe S. Ultrastructure of the mitotic apparatus in Cryptococcus neoformans. J Med Vet Mycol 1987; 25: 223–233
   Google Scholar
• Taylor JW, Wells K. A light and electron microscopic study of mitosis in Bullera alba and the histochemistry of some cytoplasmic substances. Protoplasma 1979; 98: 31–62
   Web of Science ®Google Scholar